Business Description
Abrdn Life Sciences Investors is a US-based closed-end fund that has been operating since 1992, focusing on growth opportunities within the global life sciences industry. It targets small companies across areas such as biotechnology, pharmaceuticals, medical devices, healthcare services, and agriculture. Stock selection is driven by careful research into each company's competitive strengths, leadership quality, and capacity to fund its own growth. The fund measures its results against the NASDAQ Biotech Index and the S&P 500 Index.
